ALS Ltd (ASX:ALQ): FY2026 Performance Update Highlights Testing Growth and Digital Transformation

Sonal Goyal

22 September 2026 07:30 PM AEST

ALS Ltd (ASX:ALQ): FY2026 Performance Update Highlights Testing Growth and Digital Transformation

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

ALS Ltd (ASX:ALQ) reported FY2026 performance updates across Minerals, Industrial Materials, Environmental, Food and Pharmaceutical testing businesses.
Minerals delivered 20.2% organic growth, supported by higher sample volumes and exploration testing activity.
At the time of writing on 22 September 2026, ALS Ltd (ASX:ALQ) was trading at AUD 21.39, up 0.19% during today’s trading session.
The company continued Investment in Smart Labs, automation, artificial intelligence and digital laboratory capabilities.

ALS Ltd (ASX:ALQ) provides testing solutions across minerals, environmental, industrial materials, food and pharmaceutical markets. The company has released its FY2026 Annual General Meeting update, outlining operational performance, strategic priorities, digital initiatives and progress under its Roadmap to Win strategy.

The company operates a global laboratory network and uses scientific testing capabilities to support clients across multiple industries. Its activities include analytical testing, inspection services, environmental analysis and specialised laboratory solutions.

Company Business

ALS operates through several Business divisions including Commodities, Life Sciences and Industrial Materials. The company provides testing services across the Mining value chain, environmental compliance, food safety, pharmaceuticals and industrial applications.

The Minerals business remains a major contributor within Commodities, supporting exploration testing, geochemistry, mine site testing and metallurgical services. During FY2026, Minerals delivered 20.2% organic growth and processed a record number of samples.

Industrial Materials includes Assay & Inspection, Oil & Lubricants and Coal testing services. The division recorded mixed outcomes, with Oil & Lubricants organic growth of 12.2% and Coal organic growth of 7.6%. Assay & Inspection recorded 11.4% organic growth.

Within Life Sciences, Environmental is the largest business and represented 35% of Group revenue. The division provides testing services related to environmental monitoring, compliance and emerging contaminants.

Recent Development

In July 2026, ALS released its CEO and Managing Director address for the Annual General Meeting, providing an update on FY2026 performance and future priorities.

The company outlined progress on its Roadmap to Win strategy, which focuses on customer relationships, innovation, expertise, operations, Capital allocation, culture and sustainability.

ALS also highlighted progress towards its Lab of the Future initiative. The company reported that 80% of Group Revenue is supported by a unified Laboratory Information Management System (LIMS), while its AI Marketplace has provided secure GenAI tools to more than 5,000 employees.

The company stated that more than 20 robots are in production and 115 automation opportunities are in the pipeline as part of its digital transformation activities.

Financial Performance and Sector Context

ALS reported record financial performance during FY2026, supported by growth across key testing markets. The company noted that Minerals benefited from higher exploration activity, increased sample volumes and improved pricing conditions.

The testing services sector continues to be influenced by mining activity, environmental regulation, industrial requirements and Demand for data-driven laboratory solutions. Increased focus on compliance and specialised testing supports demand across several end markets.

ALS continues to invest in automation and digital technologies, including AI-enabled laboratory processes. The company noted that approximately 60% of its cost base is labour, making productivity initiatives an important area of focus.

During FY2026, ALS reported record safety performance, with a Total Recordable Injury Frequency Rate of 0.79 and Lost Time Injury Frequency Rate of 0.29.

Risks to Consider

Key risks include changes in mining activity, Commodity cycles, regulatory requirements, laboratory capacity, technology implementation, integration of acquisitions and operational execution challenges.

Environmental testing businesses may also be affected by changes in regulation, customer demand and the pace of adoption of new testing requirements.

What to Watch Next

Future developments may include progress on Smart Labs initiatives, automation projects, hub laboratory upgrades, business performance across divisions and strategic investments.

ALS has stated that Smithfield, its Environmental hub laboratory in Sydney, is being commissioned, while the Lima Minerals hub laboratory in Peru is expected to be commissioned in November 2026.

Key Insights

ALS continues to expand its global testing platform through growth in Minerals, Environmental and other specialist testing services. The company is progressing its Roadmap to Win strategy while investing in automation, AI and laboratory technology to support future operational development.

FAQs

Q:What does ALS Ltd do?

A:ALS provides testing solutions across minerals, environmental, industrial materials, food and pharmaceutical industries.

Q:How did Minerals perform in FY2026?

A:Minerals delivered 20.2% organic growth and processed a record number of samples.

Q:What is the Lab of the Future initiative?

A:It is ALS’s digital transformation program focused on data, robotics, automation and artificial intelligence.

Q:How much Group revenue is supported by unified LIMS?

A:ALS reported that 80% of Group revenue is supported by its unified LIMS platform.

Q:What are ALS’s key markets?

A:ALS operates across commodities, life sciences and industrial materials testing markets.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.